Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
45.28%
↑ 252% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-29.73%
Historical baseline
PeriodValue
202545.28%
20243.90%
2023-27.87%
2022-0.24%
2021-80.89%
2020-79.92%
2019-98.12%
20180.00%